Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Denaturation-Enhanced Droplet Digital PCR for Liquid Biopsies.

Fitarelli-Kiehl M, Yu F, Ashtaputre R, Leong KW, Ladas I, Supplee J, Paweletz C, Mitra D, Schoenfeld JD, Parangi S, Makrigiorgos GM.

Clin Chem. 2018 Oct 1. pii: clinchem.2018.293845. doi: 10.1373/clinchem.2018.293845. [Epub ahead of print]

PMID:
30274976
2.

Enhanced detection of microsatellite instability using pre-PCR elimination of wild-type DNA homo-polymers in tissue and liquid biopsies.

Ladas I, Yu F, Leong KW, Fitarelli-Kiehl M, Song C, Ashtaputre R, Kulke M, Mamon H, Makrigiorgos GM.

Nucleic Acids Res. 2018 Jul 6;46(12):e74. doi: 10.1093/nar/gky251.

3.

Multiplexed Elimination of Wild-Type DNA and High-Resolution Melting Prior to Targeted Resequencing of Liquid Biopsies.

Ladas I, Fitarelli-Kiehl M, Song C, Adalsteinsson VA, Parsons HA, Lin NU, Wagle N, Makrigiorgos GM.

Clin Chem. 2017 Oct;63(10):1605-1613. doi: 10.1373/clinchem.2017.272849. Epub 2017 Jul 5.

4.

Methylation-sensitive enrichment of minor DNA alleles using a double-strand DNA-specific nuclease.

Liu Y, Song C, Ladas I, Fitarelli-Kiehl M, Makrigiorgos GM.

Nucleic Acids Res. 2017 Apr 7;45(6):e39. doi: 10.1093/nar/gkw1166.

5.

Comparison of multiple genotyping methods for the identification of the cancer predisposing founder mutation p.R337H in TP53.

Fitarelli-Kiehl M, Macedo GS, Schlatter RP, Koehler-Santos P, Matte Uda S, Ashton-Prolla P, Giacomazzi J.

Genet Mol Biol. 2016 Jun 3;39(2):203-9. doi: 10.1590/1678-4685-GMB-2014-0351.

6.

The breast cancer immunophenotype of TP53-p.R337H carriers is different from that observed among other pathogenic TP53 mutation carriers.

Fitarelli-Kiehl M, Giacomazzi J, Santos-Silva P, Graudenz MS, Palmero EI, Michelli RA, Achatz MI, de Toledo Osório CA, de Faria Ferraz VE, Picanço CG, Ashton-Prolla P.

Fam Cancer. 2015 Jun;14(2):333-6. doi: 10.1007/s10689-015-9779-y.

PMID:
25564201
7.

Expression of cancer stem cell markers in basal and penta-negative breast carcinomas--a study of a series of triple-negative tumors.

Uchôa Dde M, Graudenz MS, Callegari-Jacques SM, Hartmann CR, Ferreira BP, Fitarelli-Kiehl M, Edelweiss MI.

Pathol Res Pract. 2014 Jul;210(7):432-9. doi: 10.1016/j.prp.2014.03.005. Epub 2014 Mar 27.

PMID:
24726267
8.

A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil.

Giacomazzi J, Koehler-Santos P, Palmero EI, Graudenz MS, Rivero LF, Lima E, Pütten AC, Hainaut P, Camey SA, Michelli RD, Neto CS, Fitarelli-Kiehl M, Geyer G, Meurer L, Geiger A, Azevedo MB, da Silva VD, Ashton-Prolla P.

Virchows Arch. 2013 Jul;463(1):17-22. doi: 10.1007/s00428-013-1439-8. Epub 2013 Jun 21.

PMID:
23794094

Supplemental Content

Loading ...
Support Center